In another study where MALAT1 was reported to be upregulated in GBM during TMZ resistance, depletion of MALAT1 restored TMZ sensitivity through mechanistic upregulation of miR-101 and downregulation of GSK-3β in resistant GBM cells [150]. The gene discussed is MALAT1; the disease is glioblastoma.